The M2 macrophage marker CD163 was expressed higher in high-grade gliomas (p = 0.0012 (WHO II vs WHO III), p = 0.035 (WHO III vs WHO IV), Figures 8A, F–H). The gene discussed is CD163; the disease is central nervous system cancer.